- In March 2020, Agilent Technologies Inc. launched Agilent GenetiSure Cyto microarrays for prenatal and postnatal research
- In April 2020, an international collaborative alliance to improve customised medication in cancer using IndivuType, the business's multi-omics database, was established by the oncology company Indivumed GmbH
